1
/
of
0
FDA Drug Approval, N208289, AKOVAZ
FDA Drug Approval, N208289, AKOVAZ
Regular price
$89.00 USD
Regular price
Sale price
$89.00 USD
Unit price
/
per
NDA: 208289
Company: EXELA PHARMA
Drug Name: AKOVAZ
Active Ingredients: EPHEDRINE SULFATE
Strength: 25MG/5ML (5MG/ML)
Dosage Form/Route: SOLUTION;INTRAVENOUS
Action Date: 04/29/2016
Marketing Status: Prescription
Submission Classification: Type 7 - Drug Already Marketed without Approved NDA
Company: EXELA PHARMA
Drug Name: AKOVAZ
Active Ingredients: EPHEDRINE SULFATE
Strength: 25MG/5ML (5MG/ML)
Dosage Form/Route: SOLUTION;INTRAVENOUS
Action Date: 04/29/2016
Marketing Status: Prescription
Submission Classification: Type 7 - Drug Already Marketed without Approved NDA
Couldn't load pickup availability
- Status: Pending Fast-Track Request
- Delivery: Approximately 1 to 2 weeks when the FOIA office is operating at regular capacity
NOTE: This document is not currently in our library. Upon purchase, we will request the document from the FDA FOIA office. Learn more about Fast-Track Requests here.
View full details